Ceoinsights Team, 0
So far in 2021, Indian healthtech startups have attracted $1.9bn in VC investment, coming in fourth globally. The US leads with $31.9bn in VC investment, while the UK comes in third with $3.8bn, close behind China’s $4.1bn. India also ranked among the top five countries for investment into healthtech since 2016 with a total of $4.4bn, increasing ten times between 2016 and 2021.
Indian and the UK are amongst the fastest growing regions for healthtech investment, with UK healthtech VC
investment rising from just $420m in 2016 to $3.8bn, an increase by nine times and Indian health tech investment rising from $190m to $1.9bn, growing 10 times.
London and Mumbai also both feature in the top 15 list of global hubs for healthtech VC investment, demon strating increasing opportunities for collaboration between the two regions. In Europe, London is the leading hub for healthtech investment over the last five years, with investment growing 11.1 times, faster than in the Bay Area, New York and Boston. So far this year, London-based healthtech firms have received $1bn in VC investment. In Mumbai healthtech VC investment has increased from $100m in 2016 to $1.2B in 2021, clocking a record 121x growth for the period.
There has been an increase in the number of major funding rounds for Indian healthtech companies in 2021, including three rounds for PharmEasy($350m Series E in April, $500m Series F in July and $204m Series G in October) and $164m growth equity for Star Health.
Hemin Bharucha, Country Director, India, London & Partners said:“Healthtech innovation has been growing rapidly in recent years and it is fantastic to see both India and the UK attracting record levels of investment into the sector. Cities like Mumbai and London are two of the fastest growing hubs globally for healthtech investment, suggesting there are lots of opportunities for future collaboration between the two regions. We look forward to supporting Indian healthtech companies to access London’s thriving healthtech ecosystem.”
London and Mumbai also both feature in the top 15 list of global hubs for healthtech VC investment, demon strating increasing opportunities for collaboration between the two regions. In Europe, London is the leading hub for healthtech investment over the last five years, with investment growing 11.1 times, faster than in the Bay Area, New York and Boston. So far this year, London-based healthtech firms have received $1bn in VC investment. In Mumbai healthtech VC investment has increased from $100m in 2016 to $1.2B in 2021, clocking a record 121x growth for the period.
There has been an increase in the number of major funding rounds for Indian healthtech companies in 2021, including three rounds for PharmEasy($350m Series E in April, $500m Series F in July and $204m Series G in October) and $164m growth equity for Star Health.
Hemin Bharucha, Country Director, India, London & Partners said:“Healthtech innovation has been growing rapidly in recent years and it is fantastic to see both India and the UK attracting record levels of investment into the sector. Cities like Mumbai and London are two of the fastest growing hubs globally for healthtech investment, suggesting there are lots of opportunities for future collaboration between the two regions. We look forward to supporting Indian healthtech companies to access London’s thriving healthtech ecosystem.”